Log in
Enquire now
‌

US Patent 11219601 Emulsified gel composition

Patent 11219601 was granted and assigned to Hisamitsu Pharmaceutical on January, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical
0
Current Assignee
Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112196010
Patent Inventor Names
Yasuhisa Kose0
Shinya Matsumura0
Toshihiro Nakanishi0
Date of Patent
January 11, 2022
0
Patent Application Number
169751610
Date Filed
February 19, 2019
0
Patent Primary Examiner
‌
Melissa S Mercier
0
Patent abstract

The present invention provides an emulsified gel composition comprising a physiologically active substance, water, a gelling agent, an anti-peeling agent, and a surfactant having an HLB value of 18 to 20, in which the gelling agent is a nonionic water-soluble polymer, and the anti-peeling agent is one or more compounds selected from the group consisting of sucrose, sorbitol, polyethylene glycol, glycerin, a (meth)acrylic-based polymer compound, and a polyoxyethylene hydrogenated castor oil.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11219601 Emulsified gel composition

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.